Analysis of Methyl Ethane Sulfonate in Nintedanib Esylate API Sample Using Headspace-Trap Technique

Applications | 2026 | ShimadzuInstrumentation
GC/MSD, GC/MS/MS, GC/QQQ, HeadSpace
Industries
Pharma & Biopharma
Manufacturer
Shimadzu

Significance of the topic


The presence of alkyl sulfonate esters such as Methyl Ethane Sulfonate (MES) in active pharmaceutical ingredients (APIs) poses a genotoxic risk because these compounds can act as DNA-alkylating agents even at trace concentrations. Regulatory guidance (ICH M7(R2)) requires identification, assessment and appropriate control of such genotoxic impurities. Analytical methods capable of sensitive, specific and reproducible quantification at sub-ppb-to-ppb levels are therefore essential for ensuring product safety and regulatory compliance. This application focuses on quantifying MES in Nintedanib Esylate API using a headspace-trap GC–MS/MS approach to reach the low detection limits required for risk management.

Objectives and overview of the study


The primary objective was to develop and partially validate a selective, sensitive and robust method for the quantification of MES in Nintedanib Esylate API using a Shimadzu GCMS-TQ8050 NX with HS-20 NX headspace (trap) autosampler. Key goals included achieving low limits of detection and quantification suitable for pharmaceuticals even when daily doses exceed 0.3 g, demonstrating specificity versus matrix and establishing linearity, precision, and accuracy at trace levels.

Methodology


Sample preparation and extraction:
  • Diluent: ~0.83 mL concentrated HCl (~35%) diluted to 100 mL with water (acidic aqueous diluent).
  • Extraction solvent: ethyl acetate. For standards and samples, 2 mL of aqueous solution plus 2 mL ethyl acetate were vortexed, chilled and centrifuged (below 5 °C). A 100 µL aliquot of the organic layer was transferred into a 20 mL headspace vial for analysis.
  • Standards: 50 mg MES standard in 50 mL methanol to prepare 1000 ppm stock; intermediate 100 ppb standard prepared for linearity dilutions. Linearity range 0.1–10 ppb (as solution) corresponding to 1–100 ppb w.r.t. sample.

Headspace-trap methodology:
  • HS-20 NX trap mode concentrates analytes by repeated extraction/multi-injection (multi-injection count = 5), enhancing sensitivity over static headspace.
  • Key headspace parameters: trap mode; oven 120 °C; sample line 150 °C; transfer line 170 °C; trap cooling 80 °C; trap desorb 280 °C; trap equilibrium 80 °C; pressurization 150 kPa; equilibrating time 5 min; injection time 10 min; GC cycle 20 min.

GC–MS/MS conditions and MRM optimization:
  • Instrument: Shimadzu GCMS-TQ8050 NX (triple quadrupole) in MRM mode; ionization by electron impact (EI); ion source 230 °C; interface 250 °C; detector voltage +0.4 kV.
  • Column: SH-1701, 0.32 mm I.D. × 30 m, 1.0 µm film.
  • Injection: split mode, split ratio 5, helium carrier gas, linear velocity 45 cm/s.
  • Temperature program summary: 70 °C (2 min) → 25 °C/min to 150 °C (2 min) → 30 °C/min to 260 °C (4.13 min).
  • MRM transitions (optimized via Shimadzu tool) — quantifier and two qualifiers: 96.00 → 32.10 (CE 5 V, used for quantification), 96.00 → 31.00 (CE 11 V), and 66.00 → 48.00 (CE 9 V).

Instrumentation used


  • Shimadzu GCMS-TQ8050 NX triple quadrupole gas chromatograph–mass spectrometer.
  • Shimadzu HS-20 NX headspace autosampler in trap mode.
  • Column: SH-1701 (0.32 mm I.D. × 30 m, 1.0 µm film).
  • Auxiliary: centrifuge and standard volumetric glassware for sample and standard preparation.

Main results and discussion


Specificity:
There was negligible interference from the ethyl acetate blank at the MES retention time; blank signal was below the LOD, indicating method specificity for MES in the studied matrix.

Linearity:
Seven calibration levels from 0.1 to 10 ppb (injection solutions) produced an excellent correlation (r2 = 0.9999), demonstrating linear response across the target range for trace quantitation.

Limits of detection and quantification:
LOD was evaluated at 0.1 ppb (equivalent to 1 ppb w.r.t. sample) with S/N ≈ 15. LOQ was established at 0.3 ppb (3 ppb w.r.t. sample) with S/N ≈ 20; LOQ precision (%RSD) was 4.11%, indicating acceptable repeatability at the LOQ level.

Precision and system suitability:
System suitability at the chosen level (5 ppb solution; 50 ppb w.r.t. sample) showed %RSD of 3.63 for repeated injections. Method precision (six replicate spiked samples at the limit level) produced an average recovery corresponding to ~4.66 ppb (spiked at 5 ppb) with %RSD = 2.15, well within commonly accepted criteria (<15%).

Accuracy (recovery):
Recovery studies at four spike levels (0.3, 1, 5, 10 ppb as injected; equivalent to 3, 10, 50, 100 ppb w.r.t. sample) yielded average recoveries of 123.0%, 99.85%, 92.91% and 92.60%, respectively. Recoveries fell within the acceptance window of 70–130%, though the low-level spike (0.3 ppb) showed a higher bias (123%), which is typical at trace concentrations and should be considered during routine implementation.

Batch analysis:
Four production batches of Nintedanib Esylate were analyzed. Three batches showed MES levels near or below low ppb range (w.r.t sample: 19.5, 36.7 and 29.6 ppb), while one batch (Batch-3) showed substantially higher MES (561.8 ppb w.r.t. sample; 56.18 ppb in the injected solution). This demonstrates the method’s capability to detect both compliant low-level material and batches with elevated impurity content.

Benefits and practical applications of the method


  • High sensitivity: HS-trap concentration with multi-injection drastically improves detection limits versus static headspace, enabling quantitation of MES at sub-ppb injection levels (LOQ 0.3 ppb).
  • Specificity and selectivity: Triple quadrupole MRM transitions provide unambiguous identification and confirmation through one quantifier and two qualifier transitions.
  • Regulatory suitability: The workflow integrates with LabSolutions GCMS 21CFR-compliant software and supports environments requiring trace-level control of genotoxic impurities as per ICH M7(R2).
  • Robust sample handling: Simple liquid–liquid extraction using ethyl acetate and headspace trapping minimizes injection of acidic aqueous matrix into the GC, protecting column life and improving method robustness.

Future trends and potential uses


  • Broader application to other alkyl sulfonate esters and related genotoxic impurities — HS-trap GC–MS/MS can be generalized for trace-level monitoring of similar volatiles formed during API salt formation.
  • Automation and high-throughput screening — optimizing multi-injection trap cycles and autosampler schedules could increase sample throughput for routine QC while preserving sensitivity.
  • Method transfer and standardization — development of harmonized protocols and inter-laboratory comparisons would support regulatory acceptance for routine release testing and stability monitoring.
  • Integration with impurity risk assessment — combining sensitive analytical data with toxicological thresholds (e.g., TTC values) enables informed control strategies and acceptance limits for manufacturing lots.

Conclusion


The HS-20 NX trap headspace system coupled to a Shimadzu GCMS-TQ8050 NX triple quadrupole MS provides a sensitive, specific and reproducible analytical solution for quantifying Methyl Ethane Sulfonate in Nintedanib Esylate API at trace levels. The method achieves LOQ at 0.3 ppb (injection) with robust linearity (r2 = 0.9999), acceptable precision and recoveries within regulatory expectations. The trap-based headspace approach reduces matrix-related risks to the GC system and markedly enhances sensitivity, making it suitable for monitoring genotoxic esters in pharmaceutical development and quality control.

Reference


  1. Shimadzu Corporation. GCMS-TQ8050 NX with HS-20 NX (Trap) application and instrument documentation (application note, 2026).
  2. National Center for Biotechnology Information. PubChem Compound Summary for CID 135476717, Nintedanib Esylate. Accessed April 17, 2026.
  3. European Medicines Agency. Guideline on the Limits of Genotoxic Impurities; Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals: M7 (R2).
  4. Drugs.com. Dosage information for Nintedanib Esylate (reference for typical dosing and maximum daily dose).

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Analysis of Genotoxic Impurities like Ethane Sulfonic acid esters in pharmaceutical substance by GC-MS/MS
Ultra-Sensitive Dynamic Headspace GC-MS/MS Method for Trace Level Quantitation of Nitrosamines in Deferiprone API
Quantitation of 5 NSA in Metformin API as per proposed USP General Chapter <1469> Procedure-4 by GC-MS/MS
Trace Level Quantitation of 6 Nitrosamines in Metformin API by Dynamic Headspace GC-MS/MS